1 year return (CAGR)
159.52%
Palvella Therapeutics, Inc Exchange (NASDAQ, USD)
PVLA
151.69
+1.56 (+1.04%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
80.02%
5 year return (CAGR)
-18.55%
10 year return (CAGR)
1.65%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
2.19B
Price/Sales
-
Ent value
2.03B
Price/Book
10.08
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-41.62%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 150.14 |
| Daily high | 153.41 |
| Daily low | 150.14 |
| Daily Volume | 155K |
| All-time high | 756.00 |
| 1y analyst estimate | 230.53 |
| Beta | - |
| EPS (TTM) | -4.30 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| PVLA | S&P500 | |
| Current price drop from All-time high | -79.94% | -2.19% |
| Highest price drop | -99.14% | -56.47% |
| Date of highest drop | 11 Jul 2024 | 9 Mar 2009 |
| Avg drop from high | -64.85% | -10.68% |
| Avg time to new high | 40 days | 12 days |
| Max time to new high | 2157 days | 1805 days |
News
